RELISERA

Serial Number 88648042
606

Registration Progress

Application Filed
Oct 9, 2019
Under Examination
Apr 21, 2020
Approved for Publication
Feb 25, 2020
Published for Opposition
Feb 25, 2020
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: RELISERA
Previous Owner: ACERUS PHARMACEUTICALS USA, LLC
Classes: 005

Trademark Image

RELISERA

Basic Information

Serial Number
88648042
Filing Date
October 9, 2019
Published for Opposition
February 25, 2020
Abandonment Date
November 21, 2022
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 21, 2022
Classes
005

Rights Holder

ACERUS PHARMACEUTICALS USA, LLC

16
Address
500 OFFICE CENTER DRIVE
SUITE 400
FORT WASHINGTON, PA 19034

Ownership History

Serenity Pharmaceuticals LLC

Original Applicant
16
Milford, PA

Serenity Pharmaceuticals LLC

Owner at Publication
16
Mississauga, Ontario CA

ACERUS PHARMACEUTICALS USA, LLC

New Owner After Publication #1
16
FORT WASHINGTON, PA

Legal Representation

Attorney
Jessica L. Rothstein

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

27 events
Date Code Type Description Documents
Feb 1, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Nov 21, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Nov 21, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 2, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 31, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Mar 31, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
Mar 31, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 18, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 16, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Sep 16, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Sep 16, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 16, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 12, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 12, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 12, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 2, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 30, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 30, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 30, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 21, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 25, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 25, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 5, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 18, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 14, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 15, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 12, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of nocturia
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005